Kinemed, Inc.

KineMed embodies state-of-the-art Translational and Personalized Medicine based on a powerful, proprietary technical platform using stable isotopes to measure key biochemical processes in animals and man. KineMed’s novel technology stratifies patients in the clinic and evaluates patient’s responses to therapies, earlier and with more decision critical information than traditional drug development. KineMed enables rapid, cost-effective proof of concept for novel drugs and targets, increasing R&D productivity for our pharmacy partners and propelling our own pipeline of platform-advantaged compounds.